Mixed Hidden Markov Models
暂无分享,去创建一个
[1] J. Nash. Compact Numerical Methods for Computers , 2018 .
[2] L. R. Rabiner,et al. An introduction to the application of the theory of probabilistic functions of a Markov process to automatic speech recognition , 1983, The Bell System Technical Journal.
[3] James P. Hughes,et al. A class of stochastic models for relating synoptic atmospheric patterns to regional hydrologic phenomena , 1994 .
[4] N. Breslow,et al. Approximate inference in generalized linear mixed models , 1993 .
[5] J A Frank,et al. Time series for modelling counts from a relapsing-remitting disease: application to modelling disease activity in multiple sclerosis. , 1994, Statistics in medicine.
[6] J. Nelder,et al. Hierarchical Generalized Linear Models , 1996 .
[7] A. Kuk,et al. MAXIMUM LIKELIHOOD ESTIMATION FOR PROBIT-LINEAR MIXED MODELS WITH CORRELATED RANDOM EFFECTS , 1997 .
[8] C. McCulloch. Maximum Likelihood Algorithms for Generalized Linear Mixed Models , 1997 .
[9] Anders Krogh,et al. Chapter 4 - An introduction to hidden Markov models for biological sequences , 1998 .
[10] J. Rost,et al. Applications of Latent Trait and Latent Class Models in the Social Sciences , 1998 .
[11] G. Ebers,et al. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis , 1998, The Lancet.
[12] Murray A. Cameron,et al. Hidden Markov chains in generalized linear models , 1998 .
[13] Keith Humphreys,et al. The Latent Markov Chain with Multivariate Random Effects , 1998 .
[14] Anthony Y. C. Kuk,et al. Pointwise and functional approximations in Monte Carlo maximum likelihood estimation , 1999, Stat. Comput..
[15] D. Li,et al. Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis. , 1999, Annals of neurology.
[16] Martin L. Puterman,et al. Markov Poisson regression models for discrete time series. Part 1: Methodology , 1999 .
[17] D. Paty,et al. Magnetic resonance imaging results of the PRISMS trial: A randomized, double‐blind, placebo‐controlled study of interferon‐β1a in relapsing‐remitting multiple sclerosis , 1999 .
[18] A. Norheim,et al. A randomised , double-blind, placebo-controlled study , 2001 .
[19] S. R. Searle,et al. Generalized, Linear, and Mixed Models , 2005 .
[20] Richard A. C. Hughes,et al. PRISMS-4: Long-term efficacy of interferon-&bgr;-1a in relapsing MS , 2001, Neurology.
[21] Rachel J. Mackay,et al. Estimating the order of a hidden markov model , 2002 .
[22] M. Filippi,et al. MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients , 2002, Neurology.
[23] Howard Seltman,et al. Hidden Markov Models for Analysis of Biological Rhythm Data , 2002 .
[24] R. J. MacKay,et al. HIDDEN MARKOV MODELS: MULTIPLE PROCESSES AND MODEL SELECTION , 2003 .
[25] A. Petkau,et al. Application of hidden Markov models to multiple sclerosis lesion count data , 2005, Statistics in medicine.
[26] B. Silverman,et al. Maximum Penalized Likelihood Estimation , 2006 .
[27] Rachel MacKay Altman. A variance component test for mixed hidden Markov models , 2008 .
[28] Jörn Dannemann,et al. The likelihood ratio test for hidden Markov models in two-sample problems , 2008, Comput. Stat. Data Anal..